@prefix np: . @prefix npx: . @prefix ns1: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { rdf:OBJECT rdfs:label "encouraging data" . rdf:OBJECT-POSITION rdfs:label "(18, 29)" . rdf:PREDICATE rdfs:label "showed" . rdf:PREDICATE-POSITION rdfs:label "30" . rdf:SUBJECT rdfs:label "Dexamethasone and tocilizumab" . rdf:SUBJECT-POSITION rdfs:label "(18, 29)" . rdfs:label "data" . ns1:show ; rdfs:label "tocilizumab" . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" . sub:assertion prov:generatedAtTime "2023-06-01T14:26:58.016894"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377 . rdf:Statement rdfs:label "Dexamethasone and tocilizumab showed encouraging data, but Dexamethasone and tocilizumab's use needs to be further validated." . rdfs:ABSTRACT-UID rdfs:label "fp4chn9a" . rdfs:TRIPLE-UID rdfs:label "fp4chn9a-TRIPLE-ABSTRACT-1" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }